
The Fund Seeks to replicate, before fees and expenses, the total return of the S&P 500 and S&P CME Bitcoin Futures Index 75/25 Blend Index (the “Index”), an index by Standard & Poor’s. The Fund’s investment objective may be changed without the consent of the shareholders of the Fund.
Is BBB's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

New York, NY, June 22, 2026 (GLOBE NEWSWIRE) -- Matrix Applications, a leading provider of financial technology and operational solutions in the capital markets, marks its fourth year earning accreditation from the Better Business Bureau (BBB), a nonprofit organization dedicated to advancing marketplace trust by holding businesses to high standards of ethical conduct, accountability and customer care.

Laguna Hills, CA, June 15, 2026 (GLOBE NEWSWIRE) -- Glitter Bug Gold Buyers announced that the company has achieved accreditation from the Better Business Bureau (BBB) and currently maintains an A+ rating. The accreditation recognizes the company's commitment to ethical business practices, transparency, customer service standards, and marketplace integrity as it continues serving precious metals sellers throughout Orange County.

VANCOUVER, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the “Company” or “Brixton”) is pleased to announce that drilling has commenced on its fully funded 10,000-meter 2026 exploration program focused on copper and gold at its wholly owned Thorn Project in northwestern British Columbia, Canada. The Thorn Project is located approximately 90 km east-northeast of Juneau, Alaska, and 120 km west of Dease Lake, British Columbia. Drilling activities commenced on June 1st; 249 meters in three holes have been completed.

Investors searching for yield in 2026 may have reached a crossroads. They can accept the duration and default risks associated with high-yield corporate bonds.

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026